COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
- PMID: 34468820
- PMCID: PMC8409068
- DOI: 10.1007/s00134-021-06510-2
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
Conflict of interest statement
JP has received personal fees from Gilead Sciences and Pfizer, research funding from MSD and is stoke holder of AbbVie Inc and Novo Nordisk. PK is supported by the German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany and has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany, and received lecture honoraria from and/or is advisor to Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., and University Hospital, LMU Munich outside the submitted work. MH received research funding from Gilead Sciences, Astellas, Scynexis, F2G and Pfizer.
Comment on
-
COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?Intensive Care Med. 2021 Nov;47(11):1337-1338. doi: 10.1007/s00134-021-06499-8. Epub 2021 Aug 3. Intensive Care Med. 2021. PMID: 34342659 Free PMC article. No abstract available.
References
-
- Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses. 2021;64:364–371. doi: 10.1111/myc.13216. - DOI - PMC - PubMed
-
- Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth F (2021) COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases - PMC - PubMed
-
- Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Richardson R, Lagrou K, Hoenigl M (2021) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 10.1016/j.cmi.2021.08.014 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical